基础胰岛素在糖尿病患者的临床治疗中已成为糖尿病管理中的重要手段。然而临床上由于基础胰岛素使用时机的选择以及剂量调整等问题,往往使其给患者带来的临床获益并不尽如人意。笔者认为基础胰岛素在临床应用中尚有较大的改进空间。本文将就这一问题进行阐述。 Basal insulin has become an important tool in the management of diabetes in the clinical treatment of diabetic patients. However, due to the clinical choice of the timing of basal insulin use and dose adjustment, the clinical benefits to the patients are often not satisfactory. The author believes that basic insulin in the clinical application there is still much room for improvement. This article will elaborate on this issue.